PhoreMost enters multi-project drug target discovery collaboration with Roche
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a
Read more
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a
Read moreWe use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This
Read moreRecent research by a team of scientists at The Francis Crick Institute, presented at the European Society for Medical Oncology (ESMO)
Read morePhysicians may witness disagreements between co-workers, or between a co-worker and patient, that involve elements of racial bias. Or a
Read moreThis Morning's Dr Chris discusses the signs of high cholesterol We use your sign-up to provide content in ways you’ve
Read moreIn adult women, nocturnal enuresis (NE) may have urological and nonurological pathophysiology, according to a study recently published in Frontiers
Read moreWe use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This
Read moreFor patients with acute decompensated heart failure, the addition of acetazolamide to loop diuretic therapy yields an increased incidence of
Read moreIt’s best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so
Read moreType 2 diabetes affects the lives of millions of Americans and is estimated to cost $327 billion in health care
Read more